Skip to search formSkip to main contentSkip to account menu

CI 914

Known as: CI-914 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Since the introduction of theophylline (1) as the first PDE-inhibitor used in the treatment of asthma, there has been intense… 
1990
1990
The impact of changes in the activation state of the low Km cAMP phosphodiesterase (PDE) on cAMP output in adipocyte membranes… 
1990
1990
The effects of CI-914, a novel cardiotonic agent, on AA metabolism in rat neutrophils and platelets in vitro were investigated… 
1990
1990
Summary: Although recent studies indicate that MCI-154 exerts novel positive inotropic actions in heart muscle, the chronotropic… 
1987
1987
A series of 2,4-dihydro-5-[4-(1H-imidazol-1-yl)phenyl]-3H-pyrazol-3-ones was synthesized and evaluated for positive inotropic… 
1986
1986
Summary: The purpose of this study was to evaluate the effect of the new cardiotonic, imazodan (CI-914), on myocardial… 
1985
1985
In the present study, the inhibitory effects of CI-914, a novel cardiotonic agent, as well as other recently identified positive…